TipRanks
Cooper Co (MX:COO)
:COO
Mexico Market

Cooper Co (COO) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

COO Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
4 Buy
10 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Cooper
Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

COO Stock 12 Month Forecast

Average Price Target

$1,224.19
▼(-1.51% Downside)
Based on 14 Wall Street analysts offering 12 month price targets for Cooper Co in the last 3 months. The average price target is $1,224.19 with a high forecast of $1,416.16 and a low forecast of $1,095.17. The average price target represents a -1.51% change from the last price of $1,243.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"950":"$950","1215":"$1,215","1480":"$1,480","1082.5":"$1,082.5","1347.5":"$1,347.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1416.16314225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.42K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1224.194360745,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.22K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1095.16616334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.10K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[950,1082.5,1215,1347.5,1480],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,951.81,987.5294724807692,1023.2489449615384,1058.9684174423076,1094.687889923077,1130.407362403846,1166.1268348846154,1201.8463073653845,1237.5657798461539,1273.285252326923,1309.0047248076924,1344.7241972884615,1380.4436697692308,{"y":1416.16314225,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,951.81,972.7626431342308,993.7152862684615,1014.6679294026923,1035.620572536923,1056.5732156711538,1077.5258588053846,1098.4785019396154,1119.4311450738462,1140.383788208077,1161.3364313423076,1182.2890744765384,1203.2417176107692,{"y":1224.194360745,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,951.81,962.8373971799999,973.8647943599999,984.8921915399999,995.91958872,1006.9469859,1017.9743830799999,1029.00178026,1040.02917744,1051.05657462,1062.0839718,1073.11136898,1084.13876616,{"y":1095.16616334,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1222.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1285,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1425.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1459.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1479.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1415.95,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1251,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1221,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1069,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1162.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1243,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1243,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":951.81,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,416Average Price Target$1,224Lowest Price Target$1,095
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$1,132.93
Hold
-8.86%
Downside
Reiterated
10/28/26
Cooper Co (COO) Receives a Hold from Barclays
Piper Sandler Analyst forecast on MX:COO
Piper Sandler
Piper Sandler
$1,114.05
Hold
-10.37%
Downside
Reiterated
10/28/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Repligen (NASDAQ: RGEN) and Cooper Co (NASDAQ: COO)
Citi
$1,132.93
Hold
-8.86%
Downside
Reiterated
10/02/26
Citi Sticks to Its Hold Rating for Cooper Co (COO)
Stifel Nicolaus Analyst forecast on MX:COO
Stifel Nicolaus
Stifel Nicolaus
$1,321.75
Buy
6.34%
Upside
Reiterated
10/01/26
Analysts Offer Insights on Healthcare Companies: Cooper Co (NASDAQ: COO), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and CervoMed (NASDAQ: CRVO)
William Blair Analyst forecast on MX:COO
William Blair
William Blair
―
Hold
―
Downgraded
09/12/26
Cooper Companies downgraded to Market Perform from Outperform at William BlairCooper Companies downgraded to Market Perform from Outperform at William Blair
Mizuho Securities Analyst forecast on MX:COO
Mizuho Securities
Mizuho Securities
$1,604.98→$1,416.16
Buy
13.93%
Upside
Reiterated
09/11/26
Cooper Companies price target lowered to $75 from $85 at MizuhoCooper Companies price target lowered to $75 from $85 at Mizuho
Robert W. Baird Analyst forecast on MX:COO
Robert W. Baird
Robert W. Baird
$1,604.98→$1,151.81
Hold
-7.34%
Downside
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Outperform at BairdCooper Companies downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on MX:COO
J.P. Morgan
J.P. Morgan
$1,340.63→$1,095.17
Hold
-11.89%
Downside
Assigned
09/10/26
Cooper Companies price target lowered to $58 from $71 at JPMorganCooper Companies price target lowered to $58 from $71 at JPMorgan
Bank of America Securities Analyst forecast on MX:COO
Bank of America Securities
Bank of America Securities
$1,510.57→$1,227.34
Hold
-1.26%
Downside
Downgraded
09/10/26
Cooper Co (COO) was downgraded to a Hold Rating at Bank of America Securities
Needham
$1,623.87→$1,378.4
Buy
10.89%
Upside
Reiterated
09/10/26
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)
KeyBanc
―
Hold
―
Reiterated
09/10/26
Analysts Conflicted on These Healthcare Names: Telix Pharmaceuticals (Other OTC: TLPPF) and Cooper Co (NASDAQ: COO)
UBS
$1,416.16→$1,246.22
Hold
0.26%
Upside
Assigned
09/10/26
Cooper Companies price target lowered to $66 from $75 at UBSCooper Companies price target lowered to $66 from $75 at UBS
Jefferies Analyst forecast on MX:COO
Jefferies
Jefferies
$1,604.98→$1,321.75
Buy
6.34%
Upside
Reiterated
09/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on MX:COO
Wells Fargo
Wells Fargo
$1,246.22→$1,151.81
Hold
-7.34%
Downside
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Brainsway (NASDAQ: BWAY), Cooper Co (NASDAQ: COO) and Arcus Biosciences (NYSE: RCUS)
Goldman Sachs Analyst forecast on MX:COO
Goldman Sachs
Goldman Sachs
$1,302.87→$1,151.81
Sell
-7.34%
Downside
Reiterated
05/27/26
Cooper Companies price target lowered to $61 from $69 at Goldman SachsCooper Companies price target lowered to $61 from $69 at Goldman Sachs
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$1,132.93
Hold
-8.86%
Downside
Reiterated
10/28/26
Cooper Co (COO) Receives a Hold from Barclays
Piper Sandler Analyst forecast on MX:COO
Piper Sandler
Piper Sandler
$1,114.05
Hold
-10.37%
Downside
Reiterated
10/28/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Repligen (NASDAQ: RGEN) and Cooper Co (NASDAQ: COO)
Citi
$1,132.93
Hold
-8.86%
Downside
Reiterated
10/02/26
Citi Sticks to Its Hold Rating for Cooper Co (COO)
Stifel Nicolaus Analyst forecast on MX:COO
Stifel Nicolaus
Stifel Nicolaus
$1,321.75
Buy
6.34%
Upside
Reiterated
10/01/26
Analysts Offer Insights on Healthcare Companies: Cooper Co (NASDAQ: COO), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and CervoMed (NASDAQ: CRVO)
William Blair Analyst forecast on MX:COO
William Blair
William Blair
―
Hold
―
Downgraded
09/12/26
Cooper Companies downgraded to Market Perform from Outperform at William BlairCooper Companies downgraded to Market Perform from Outperform at William Blair
Mizuho Securities Analyst forecast on MX:COO
Mizuho Securities
Mizuho Securities
$1,604.98→$1,416.16
Buy
13.93%
Upside
Reiterated
09/11/26
Cooper Companies price target lowered to $75 from $85 at MizuhoCooper Companies price target lowered to $75 from $85 at Mizuho
Robert W. Baird Analyst forecast on MX:COO
Robert W. Baird
Robert W. Baird
$1,604.98→$1,151.81
Hold
-7.34%
Downside
Downgraded
09/10/26
Cooper Companies downgraded to Neutral from Outperform at BairdCooper Companies downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on MX:COO
J.P. Morgan
J.P. Morgan
$1,340.63→$1,095.17
Hold
-11.89%
Downside
Assigned
09/10/26
Cooper Companies price target lowered to $58 from $71 at JPMorganCooper Companies price target lowered to $58 from $71 at JPMorgan
Bank of America Securities Analyst forecast on MX:COO
Bank of America Securities
Bank of America Securities
$1,510.57→$1,227.34
Hold
-1.26%
Downside
Downgraded
09/10/26
Cooper Co (COO) was downgraded to a Hold Rating at Bank of America Securities
Needham
$1,623.87→$1,378.4
Buy
10.89%
Upside
Reiterated
09/10/26
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)
KeyBanc
―
Hold
―
Reiterated
09/10/26
Analysts Conflicted on These Healthcare Names: Telix Pharmaceuticals (Other OTC: TLPPF) and Cooper Co (NASDAQ: COO)
UBS
$1,416.16→$1,246.22
Hold
0.26%
Upside
Assigned
09/10/26
Cooper Companies price target lowered to $66 from $75 at UBSCooper Companies price target lowered to $66 from $75 at UBS
Jefferies Analyst forecast on MX:COO
Jefferies
Jefferies
$1,604.98→$1,321.75
Buy
6.34%
Upside
Reiterated
09/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on MX:COO
Wells Fargo
Wells Fargo
$1,246.22→$1,151.81
Hold
-7.34%
Downside
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Brainsway (NASDAQ: BWAY), Cooper Co (NASDAQ: COO) and Arcus Biosciences (NYSE: RCUS)
Goldman Sachs Analyst forecast on MX:COO
Goldman Sachs
Goldman Sachs
$1,302.87→$1,151.81
Sell
-7.34%
Downside
Reiterated
05/27/26
Cooper Companies price target lowered to $61 from $69 at Goldman SachsCooper Companies price target lowered to $61 from $69 at Goldman Sachs
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
REPLReplimune Group
VSTMVerastem
OVIDOvid Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cooper Co

3 Months
Anthony PetroneMizuho Securities
Success Rate
18/31 ratings generated profit
58%
Average Return
+3.05%
Copying Anthony Petrone's trades and holding each position for 3 Months would result in 58.06% of your transactions generating a profit, with an average return of +3.05% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
19/31 ratings generated profit
61%
Average Return
+3.86%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 61.29% of your transactions generating a profit, with an average return of +3.86% per trade.
2 Years
Jonathan BlockStifel Nicolaus
Success Rate
13/30 ratings generated profit
43%
Average Return
-0.11%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 43.33% of your transactions generating a profit, with an average return of -0.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

COO Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
9
8
9
6
7
Hold
6
7
6
12
15
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
16
16
15
18
22
In the current month, COO has received 7 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. COO average Analyst price target in the past 3 months is 1,224.19.
Each month's total comprises the sum of three months' worth of ratings.

COO Financial Forecast

COO Earnings Forecast

Next quarter’s earnings estimate for COO is $19.95 with a range of $19.56 to $20.18. The previous quarter’s EPS was $21.49. COO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year COO has Performed in-line its overall industry.
Next quarter’s earnings estimate for COO is $19.95 with a range of $19.56 to $20.18. The previous quarter’s EPS was $21.49. COO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year COO has Performed in-line its overall industry.

COO Sales Forecast

Next quarter’s sales forecast for COO is $19.95B with a range of $19.83B to $20.08B. The previous quarter’s sales results were $19.92B. COO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year COO has Performed in-line its overall industry.
Next quarter’s sales forecast for COO is $19.95B with a range of $19.83B to $20.08B. The previous quarter’s sales results were $19.92B. COO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year COO has Performed in-line its overall industry.

COO Stock Forecast FAQ

What is MX:COO’s average 12-month price target, according to analysts?
Based on analyst ratings, Cooper Co’s 12-month average price target is 1,224.19.
    What is MX:COO’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:COO, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cooper Co a Buy, Sell or Hold?
        Cooper Co has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 10 hold ratings and 0 sell ratings.
          What is Cooper Co’s share price target?
          The average share price target for Cooper Co is 1,224.19. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,416.16 ,and the lowest forecast is $1,095.17. The average share price target represents -1.51% Decrease from the current price of $1,243.
            What do analysts say about Cooper Co?
            Cooper Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
              How can I buy shares of Cooper Co?
              To buy shares of MX:COO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.